Men could soon have a new reliable contraception. The Contraline company develops a male contraceptive implant. The product completed the first phase of clinical trials with encouraging results.
The Adam implant is made up of hydrogel, an insoluble polymer that prevents sperm from reaching the prostate. Man can always ejaculate, but his sperm no longer contains sperm. According to the first results of the clinical trials carried out on 25 participants, the contraceptive frost, which injects into the scrotum, would have an effectiveness of two years, after which it would dissolve naturally, thus allowing the user to regain his fertility.
An alternative to vasectomy
The results have not yet been published in a scientific journal, which is necessary to be validated within the scientific community. The second phase of clinical trials should start during the year in Australia with 30 to 50 participants.
This non -invasive contraceptive must still prove its effectiveness and obtain the necessary authorizations before being marketed. It could constitute an alternative to condoms or vasectomy. The latter is not reversible in the majority of cases.
Today, contraception is essentially based on women, who have an important contraceptive arsenal at their disposal. Conversely, men have only few alternatives pending the placing on the market of other treatment currently under study.
